The mechanism of CD47-dependent killing of T cells: Heterotrimeric Gi-dependent inhibition of protein kinase A1

Journal of Immunology

Volumn 170, Issue 7, 2003, Pages 3544-3553

  Manna, Partha Pratim ^a   Frazier, William A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CASPASE; CD3 ANTIGEN; CD47 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DNA FRAGMENT; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1F7; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PERTUSSIS TOXIN; PROTEIN BCL 2; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037378747     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.7.3544     Document Type: Article

References (55)

1. Wesselborg, S., O. Janssen, and D. J. Kabelitz. 1993. Induction of activation driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
2. Radvanyi, L., G. B. Mills, and R. G. Miller. 1993. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol. 150:5704.
3. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
4. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jinkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
5. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thomson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
6. Gribben, J. G., G. J. Freeman, V. A. Boussiotis, P. Rennert, C. L. Jellis. E. Greenfield, M. Barber, V. A. Restivo, Jr., X. Ke, and G. S. Gray. 1995. CTLA-4 mediates antigen specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811.
7. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Grisser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
8. Brown, E. J., and W. A. Frazier. 2001. Integrin associated protein (CD47) and its ligands. Trends Cell Biol. 11:130.
9. Riessen, R., M. Kearney, J. Lawler, and J. M. Isner. 1998. Immunolocalization of thrombospondin-I in human atherosclerotic and restenotic arteries. Am. Heart J. 135:357.
10. Reed, M. J., L. Irueta-Arispe, E. R. O'Brien, T. Truong, T. Labell, P. Bornstein, and E. H. Sage. 1995. Expression of thrombospondins by endothelial cells: injury is correlated with TSP-I. Am. J. Pathol. 147:1068.
11. Brown, E. J., L. Hopper, T. Ho, and H. D. Gresham. 1990. Integrin associated protein: a 50-kilodalton plasma membrane antigen physically and functionally associated with integrins. J. Cell Biol. 111:2785.
12. Gao, A. G., F. P. Lindberg, J. M. Dimitry, E. J. Brown, and W. A. Frazier. 1996. Thrombospondin modulates αvβ3 function through integrin associated protein. J. Cell Biol. 135:533.
13. 3. J. Biol. Chem. 272:14740.
14. Cooper, D., F. P. Lindberg, J. R. Gamble, E. J. Brown, and M. A. Vadas. 1995. The transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc. Natl. Acad. Sci. USA 92:3978.
15. Parkos, C. A., S. P. Colgan, T. W. Liang, A. Nusrat, A. E. Bacarra, D. K. Carnes, and J. L. Madara. 1996. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J. Cell Biol. 132:437.
16. Ticchioni, M., M. Deckert. F. Mary, G. Bernard, E. J. Brown, and A. Bernard. 1997. Integrin associated protein (CD47) is a comitogenic molecule on CD3 activated human T cells. J. Immunol. 158:677.
17. Reinhold, M. I., F. P. Lindberg, G. J. Kersh, P. M. Allen, and E. J. Brown. 1997. Costimulation of T cell activation by integrin associated protein (CD47) is an adhesion dependent, CD28 independent signaling pathway. J. Exp. Med. 185:1.
18. Avice, M.-N., M. Rubio, M. Sergerie, G. Delespesse, and M: Sarfati. 2000. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. J. Immunol. 165:4624.
19. Avice, M.-N., M. Rubio, M. Sergerie, G. Delespesse, and M. Sarfati. 2001. Role of CD47 in the induction of human naive T cell anergy. J. Immunol. 167:2459.
20. Waclavicek, M., O. Majdic, T. Stulnig, M. Berger, T. Baumruker, W. Knapp, and W. F. Pickl. 1997. T cell stimulation via CD47: agonist and antagonistic effects of CD47 monoclonal antibody I/IA4. J. Immunol. 159:5345.
21. Demeure, C. E., H. Tanaka, V. Mateo, M. Rubin, G. Delespesse, and M. Sarfati. 2000. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 164:2193.
22. Li, Z., L. He, K. E. Wilson, and D. D. Roberts. 2001. Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J. Immunol. 166:2427.
23. Pettersen, R. D., K. Hestdal, M. K. Olafsen, S. O. Lie, and F. P. Lindberg. 1999. CD47 signals T cell death. J. Immunol. 162:7031.
24. Mateo, V., L. Lagneaux, D. Bron, G. Biron, M. Armant, G. Delespesse, and M. Sarfati. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat. Med. 5:1277.
25. Frazier, W. A., A. G. Gao, J. Dimitry, J. Chung, E. J. Brown, F. P. Lindberg, and M. E. Linder. 1999. The thrombospondin receptor integrin associated protein (CD47) functionally couples to heterotrimeric Gi. J. Biol. Chem. 274:8554.
26. Green, J. M., A. Zhelesnyak, J. Chung, F. P. Lindberg, M. Sarfati, W. A. Frazier, and E. J. Brown. 1999. Role of cholesterol in formation and function of a signaling complex involving αVβ3 integrin associated protein (CD47), and heterotrimeric G proteins. J. Cell Biol. 146:673.
27. Wilson, K. E., Z. Li, M. Kara, K. L. Gardner, and D. D. Roberts. 1999. β1 integrin and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides. J. Immunol. 163:3621.
28. Wang, X. Q., F. P. Lindberg, and W. A. Frazier, 1999. Integrin-associated protein stimulates α2β1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinase. J. Cell Biol. 147:389.
29. Chung, J., X. Q. Wang, F. P. Lindberg, and W. A. Frazier. 1999. Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in α2β1 mediated platelet activation. Blood 94:642.
30. Lindberg, F. P., H. D. Gresham, E. Schwarz, and E. J. Brown. 1993. Molecular cloning of integrin associated protein: an immunoglobulin family member with multiple membrane spanning domains implicated in αvβ3-dependent ligand binding. J. Cell Biol. 123:485.
31. Reinhold, M. I., F. P. Lindberg, D. Plas, S. Reynolds, M. G. Peters, and E. J. Brown. 1995. In vivo expression of alternatively spliced forms of integrin associated protein (CD47). J. Cell Sci. 108:3419.
32. Reinhold, M. I., J. M. Green, F. P. Lindberg, M. Ticchioni, and E. J. Brown. 1999. Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28. Int. Immunol. 11:707.
33. Manna. P. P., B. Duffy, B. Olack, J. Lowell, and T. Mohanakumar. 2001. Activation of human dendritic cells by porcine aortic endothelial cells: transactivation of naive T cells through costimulation and cytokine generation. Transplantation 72:1563.
34. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J. L. Vayssiere, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed cell death in vivo. J. Exp. Med. 181:1661.
35. Marchetti, P., M. Castedo, S. A. Susin, N. Zamzami, T. Hirsch, A. Macho, A. Haeffner, F. Hirsch, M. Geuskens, and G. Kroemer. 1996. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1155.
36. Neer, E. J. 1995. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249.
37. Martin, M. C., I. Dransfield, C. Haslett, and A. Rossi. 2001. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276:45041.
38. Parvathenani, L. K., E. S. Buescher, E. Chacon-Cruz, and S. J. Beebes. 1998. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase 3. J. Biol. Chem. 273:6736.
39. Garcia-Barmejo, L., C. Perez, N. E. Vilaboa, E. de Blas, and P. Alter. 1998. cAMP increasing agent attenuates the generation of apoptosis by etoposide in promonocytic leukemia cells. J. Cell Sci. 111:637.
40. Orlov, S. N., N. Thorin-Trescases, N. O. Dulin, T. V. Dam, M. A. Fortuno, J. Tremblay, and P. Hamet. 1999. Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase 3. Cell Death Differ. 6:661.
41. Li, Z., M. J. Calzada, J. M. Sipes, J. A. Cashel, H. C. Krutzsch, D. S. Annis, D. E. Mosher, and D. D. Roberts. 2002. Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior. J. Cell Biol. 157:509.
42. Chung, S., T. L. Gumienny, M. O. Hengartner, and M. Driscoll. 2000. A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nat. Cell Biol. 2:931.
43. Rathmell, J. C., and C. B. Thompson. 2002. Pathways of apoptosis in lymphocyte development, homeostasis and disease. Cell 109:S97.
44. McCarthy, N. J., M. K. B. Whyte, C. S. Gilbert, and G. I. Evan. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage or the Bcl-2 homolog Bak. J. Cell Biol. 136:215.
45. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309.
46. Williams, C. B., D. L. Engle, G. J. Kersh, J. M. White, and P. M. Allen. 1999. A kinetic threshold between negative and positive selection based on the longevity of the TCR-ligand complex. J. Exp. Med. 189:1531.
47. Uchida-Oka, N., and M. Sugimoto. 2001. Norepinephrine induces in skin melanophores by attenuating cAMP-PKA signals via α2-adrenoreceptors in the medaka, Oryzias latipes. Pigm. Cell. Res. 14:356.
48. Igaz, L. M., D. Refozo, M. A. Costas, F. Holsboer, and E. Arzt. 2002. CRE-mediated transcriptional activation is involved in cAMP protection of T cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death. Biochim. Biophys. Acta 1542:139.
49. Yusta, B., J. Estall, and D. J. Drucker. 2002. Glucagon-like peptide-2 receptor activation engages Bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 277:24896.
50. Harada, H., B. Becknell, M. Wilm, M. Mann, L. J. Huang, S. S. Taylor, J. D. Scott, and S. J. Korsmeyer. 1999. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3:413.
51. Laudanna, C., J. J. Campbell. and E. C. Butcher. 1997. Elevation of intracellular cAMP inhibits Rho activation and integrin dependent leukocyte adhesion induced by chemoattractants. J. Biol. Chem. 272:24141.
52. Stupack, D. G., X. S. Puentes, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh. 2001. Apoptosis of adherent cells by recruitment of caspase 8 to unligated integrins. J. Cell Biol. 155:459.
53. Oldenborg, P. A., H. D. Gresham, Y. Chen, S. Izui, and F. P. Lindberg. 2002. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 99:3500.
54. Blazar, B. R., F. P. Lindberg, E. Ingulli, A. Panoskaltis-Mortari, P. A. Oldenborg, K. Iizuka, W. M. Yokoyama, and P. A. Taylor. 2001. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J. Exp. Med. 194:541.
55. Lindberg, F. P., D. C. Bullard, T. E. Caver, H. D. Gresham, A. L. Beaudet, and E. J. Brown. 1996. Decreased resistance of bacterial infection and granulocyte defects in IAP-deficient mice. Science 274:795.